William Blair restated their hold rating on shares of LifePoint Health (NASDAQ:LPNT) in a research note released on Friday morning.

Other research analysts have also issued research reports about the stock. Mizuho set a $65.00 price target on shares of LifePoint Health and gave the stock a hold rating in a research report on Monday, July 23rd. BMO Capital Markets increased their price target on shares of LifePoint Health from $62.00 to $65.00 and gave the stock a market perform rating in a research report on Tuesday, July 24th. ValuEngine raised shares of LifePoint Health from a sell rating to a hold rating in a research report on Tuesday, July 24th. Zacks Investment Research lowered shares of LifePoint Health from a buy rating to a hold rating in a report on Monday, July 16th. Finally, BidaskClub raised shares of LifePoint Health from a buy rating to a strong-buy rating in a report on Friday, May 4th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $58.73.

NASDAQ:LPNT opened at $64.45 on Friday. LifePoint Health has a 12-month low of $41.45 and a 12-month high of $65.35. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.85 and a quick ratio of 1.63. The stock has a market capitalization of $2.50 billion, a P/E ratio of 17.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.71.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings results on Friday, July 27th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.19. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The firm had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the business posted $0.96 earnings per share. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. equities analysts predict that LifePoint Health will post 4.59 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of LPNT. Point72 Asia Hong Kong Ltd increased its holdings in shares of LifePoint Health by 1,897.5% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock worth $114,000 after buying an additional 2,296 shares in the last quarter. Bank of Montreal Can acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $169,000. Campbell & CO Investment Adviser LLC acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $211,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $219,000. Finally, Verition Fund Management LLC acquired a new stake in shares of LifePoint Health in the first quarter valued at approximately $224,000.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Featured Story: Price to Earnings Ratio (PE) Basics

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.